Association of GST M1 null polymorphism with Parkinson's disease in a Chilean population with a strong Amerindian genetic component

被引:29
|
作者
Perez-Pastene, Carolina
Graurnann, Rebecca
Diaz-Grez, Fernando
Miranda, Marcelo
Venegas, Pablo
Godoy, Osvaldo Trujillo
Layson, Luis
Villagra, Roque
Matamala, Jose Manuel
Herrera, Luisa
Segura-Aguilar, Juan
机构
[1] Univ Chile, Fac Med, ICBM, Santiago 7, Chile
[2] Univ Chile, Fac Med, ICBM, Santiago 7, Chile
[3] Clin Las Condes, Santiago, Chile
关键词
polymorphism; glutathione transferase; Parkinson's disease; dopamine; aminochrome;
D O I
10.1016/j.neulet.2007.03.024
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
We have studied the association of a null mutation of Glutathione Transferase M1 (GST M1 *0/0) with Parkinson's disease (MIM 168600) in a Chilean population with a strong Amerindian genetic component. We determined the genotype in 349 patients with idiopathic Parkinson's disease (174 female and 175 male; 66.84 +/- 10.7 years of age), and compared that to 611 controls (457 female and 254 male; 62 +/- 13.4 years of age). A significant association of the null mutation in GST MI with Parkinson's disease was found (p = 0.021), and the association was strongest in the earlier age range. An association of GSTM1 *0/0 with Parkinson's disease supports the hypothesis that Glutathione Transferase MI plays a role in protecting astrocytes against toxic dopamine oxidative metabolism, and most likely by preventing toxic one-electron reduction of aminochrome. (C) 2007 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:181 / 185
页数:5
相关论文
共 50 条
  • [31] Association between the debrisoquine hydroxylase gene polymorphism and the genetic susceptibility of Parkinson's disease
    Tao, Enxiang
    Liu, Zhuolin
    Chen, Biao
    Pan, Xibang
    Shao, Ming
    Zhonghua Yixue Yichuanxue Zazhi/Chinese Journal of Medical Genetics, 1998, 15 (05): : 281 - 283
  • [32] Association between genetic polymorphism of angiotensin converting enzyme gene and Parkinson's disease
    Lin, JJ
    Yueh, KY
    Chang, DC
    MOVEMENT DISORDERS, 2002, 17 : S31 - S31
  • [33] Association study of rs6812193 polymorphism with Parkinson's disease in a Greek population
    Kalinderi, Kallirhoe
    Bostantjopoulou, Sevasti
    Katsarou, Zoe
    Fidani, Liana
    NEUROSCIENCE LETTERS, 2013, 541 : 190 - 192
  • [34] No association of PARK10 polymorphism with Parkinson's disease in Han Chinese population
    Tian, Sijia
    Yang, Xinglong
    Zhao, Quanzhen
    Zheng, Jinhua
    Huang, Hongyan
    Chen, Yalan
    An, Ran
    Xu, Yanming
    PARKINSONISM & RELATED DISORDERS, 2017, 42 : 105 - 106
  • [35] L-myc, GST M1 genetic polymorphism and hepatocellular carcinoma risk among chronic hepatitis B carriers
    Hsieh, LL
    Huang, RC
    Yu, MW
    Chen, CJ
    Liaw, YF
    CANCER LETTERS, 1996, 103 (02) : 171 - 176
  • [36] Cueing-Dependent Activity in Bilateral M1 in Parkinson's Disease
    Daffertshofer, Andreas
    Vardy, Alistair N.
    van Wegen, Erwin E. H.
    ADVANCES IN COGNITIVE NEURODYNAMICS (II), 2011, : 747 - 752
  • [37] Genetic Association Between KIBRA Polymorphism and Alzheimer’s Disease with in a Japanese Population
    Eri Kawai
    Nobuto Shibata
    Tomoyuki Nagata
    Shunichiro Shinagawa
    Kenji Tgai
    Tohru Ohnuma
    Hiromi Shimazaki
    Aiko Toda
    Koji Kasanuki
    Toshiki Takayama
    Ayako Suzuki
    Kazuhiko Nakayama
    Hisashi Yamada
    Heii Arai
    NeuroMolecular Medicine, 2015, 17 : 170 - 177
  • [38] M1 AND M2 IMMUNE ACTIVATION IN PARKINSON'S DISEASE: FOE AND ALLY?
    Moehle, M. S.
    West, A. B.
    NEUROSCIENCE, 2015, 302 : 59 - 73
  • [39] Association of genetic polymorphism of glutathione S-transferase M1,T1, P1 and susceptibility to bladder cancer
    Srivastava, DSL
    Mishra, DK
    Mandhani, A
    Mittal, B
    Kumar, A
    Mittal, RD
    EUROPEAN UROLOGY, 2005, 48 (02) : 339 - 344
  • [40] Genetic polymorphism of paraoxonase 1 (PON1) and susceptibility to Parkinson's disease
    Kondo, I
    Yamamoto, M
    BRAIN RESEARCH, 1998, 806 (02) : 271 - 273